Floatz logo

cd147-cart

CD147 Positive

Xijing HospitalCell therapyEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the CD147 Positive cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

cd147-cart is also rated in:

hepatocellular carcinomaDormant
CC
Indicative ·
41 / 100
View asset →
glioblastomaDormant
C
Indicative ·
38 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →